Want to join the conversation?
$DPS's sales for 3Q15 rose by about 3% from last year. The drivers of increase in sales were 3% increase in concentrate case sales, favorable product and package mix and higher pricing, partially offset by $39MM in unfavorable foreign currency translation and higher discounts primarily driven by its fountain business.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)